Literature DB >> 16108769

Cytokine profile of peripheral blood mononuclear cells from patients with different outcomes of hepatitis C virus infection.

A Gramenzi1, P Andreone, E Loggi, F G Foschi, C Cursaro, M Margotti, M Biselli, M Bernardi.   

Abstract

SUMMARY: The relationship between the balance of helper T-cell type 1 (Th1) or type 2 (Th2) cytokines and the clinical course of hepatitis C virus (HCV) infection is unclear. We evaluated Th1 [interleukin (IL)-2, interferon-gamma (IFN-gamma)] and Th2 cytokine (IL-4, IL-10) and 2,5-oligoadenylate synthetase (OAS, an IFN-induced antiviral protein) production by peripheral blood mononuclear cells from 10 healthy anti-HCV-positive individuals (group A), 10 HCV-RNA-positive with persistently normal alanine aminotransferase (ALT) levels (group B), 10 HCV-RNA-positive with abnormal ALT (group C) and 10 uninfected healthy controls. IL-2 production was significantly increased in group B when compared with all the other groups. No difference was found for IFN-gamma. IL-4 was significantly higher in group C than in both group B (P = 0.0006) and controls (P = 0.004). Compared with controls, IL-10 was significantly decreased in group A (P = 0.013) and B (P = 0.004). The production of 2,5-OAS was significantly higher in group B than in A (P = 0.04) and in C (P = 0.004). Finally, in all HCV-RNA-positive patients, a significant correlation was found between ALT and both IL-2 (r = -0.78; P = 0.0008) and IL-4 (r = 0.75; P = 0.0008). IN
CONCLUSION: (i) subjects who cleared HCV showed a cytokine profile similar to controls; (ii) a preferential shift towards a Th1 profile seems associated with a more favourable clinical outcome in chronic hepatitis C; and (iii) a prevalent Th2 profile seems implicated in HCV pathogenesis and severity of liver disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16108769     DOI: 10.1111/j.1365-2893.2005.00634.x

Source DB:  PubMed          Journal:  J Viral Hepat        ISSN: 1352-0504            Impact factor:   3.728


  21 in total

1.  Inflammation biomarkers in chronic hepatitis C: association with liver histopathology, HCV genotype and cryoglobulinemia.

Authors:  Maria Atta; Milena Cabral; Gilvan Santos; Raymundo Paraná; Ajax Atta
Journal:  Inflamm Res       Date:  2012-06-21       Impact factor: 4.575

2.  Antioxidant and immunomodulatory effects of Viusid in patients with chronic hepatitis C.

Authors:  Eduardo Vilar Gomez; Yadina Martinez Perez; Hector Vega Sanchez; Gretel Riveron Forment; Enrique Arus Soler; Luis Calzadilla Bertot; Ali Yasells Garcia; Maria del Rosario Abreu Vazquez; Licet Gonzalez Fabian
Journal:  World J Gastroenterol       Date:  2010-06-07       Impact factor: 5.742

3.  Integrated Multi-Omics Data Analysis Reveals Associations Between Glycosylation and Stemness in Hepatocellular Carcinoma.

Authors:  Peiyan Liu; Qi Zhou; Jia Li
Journal:  Front Oncol       Date:  2022-06-23       Impact factor: 5.738

4.  Polymorphisms of some cytokines and chronic hepatitis B and C virus infection.

Authors:  Qiu-Ju Gao; Dian-Wu Liu; Shi-Yong Zhang; Min Jia; Li-Min Wang; Li-Hong Wu; Shu-Yun Wang; Li-Xin Tong
Journal:  World J Gastroenterol       Date:  2009-11-28       Impact factor: 5.742

5.  Interleukin-6 is associated with noninvasive markers of liver fibrosis in HIV-infected patients with alcohol problems.

Authors:  Daniel Fuster; Judith I Tsui; Debbie M Cheng; Emily K Quinn; Kaku A Armah; David Nunes; Matthew S Freiberg; Jeffrey H Samet
Journal:  AIDS Res Hum Retroviruses       Date:  2013-05-17       Impact factor: 2.205

6.  IFN-γ (+874) and not TNF-α (-308) is associated with HBV-HCC risk in India.

Authors:  Roli Saxena; Yogesh Kumar Chawla; Indu Verma; Jyotdeep Kaur
Journal:  Mol Cell Biochem       Date:  2013-10-08       Impact factor: 3.396

7.  Viusid, a nutritional supplement, increases survival and reduces disease progression in HCV-related decompensated cirrhosis: a randomised and controlled trial.

Authors:  Eduardo Vilar Gomez; Yoan Sanchez Rodriguez; Ana Torres Gonzalez; Luis Calzadilla Bertot; Enrique Arus Soler; Yadina Martinez Perez; Ali Yasells Garcia; Maria Del Rosario Abreu Vazquez
Journal:  BMJ Open       Date:  2011-01-01       Impact factor: 2.692

8.  Markers of inflammation and fibrosis in alcoholic hepatitis and viral hepatitis C.

Authors:  Manuela G Neuman; Hemda Schmilovitz-Weiss; Nir Hilzenrat; Marc Bourliere; Patrick Marcellin; Cristhian Trepo; Tony Mazulli; George Moussa; Ankit Patel; Asad A Baig; Lawrence Cohen
Journal:  Int J Hepatol       Date:  2012-02-22

9.  Distinct immunoregulatory cytokine pattern in Egyptian patients with occult Hepatitis C infection and unexplained persistently elevated liver transaminases.

Authors:  Yahia Z Gad; Narres Mouas; Azza Abdel-Aziz; Nashwa Abousmra; Mona Elhadidy
Journal:  Asian J Transfus Sci       Date:  2012-01

Review 10.  Inflammation and repair in viral hepatitis C.

Authors:  Manuela G Neuman; Kevin Sha; Rustan Esguerra; Sam Zakhari; Robert E Winkler; Nir Hilzenrat; Jonathan Wyse; Curtis L Cooper; Devanshi Seth; Mark D Gorrell; Paul S Haber; Geoffrey W McCaughan; Maria A Leo; Charles S Lieber; Mihai Voiculescu; Eugenia Buzatu; Camelia Ionescu; Jozsef Dudas; Bernhard Saile; Giuliano Ramadori
Journal:  Dig Dis Sci       Date:  2008-06       Impact factor: 3.487

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.